GTBP
Price
$2.79
Change
-$0.30 (-9.68%)
Updated
Jul 3, 02:00 PM (EDT)
Capitalization
10.7M
SLGL
Price
$7.37
Change
-$0.10 (-1.34%)
Updated
Jul 3, 02:00 PM (EDT)
Capitalization
20.42M
35 days until earnings call
Interact to see
Advertisement

GTBP vs SLGL

Header iconGTBP vs SLGL Comparison
Open Charts GTBP vs SLGLBanner chart's image
GT Biopharma
Price$2.79
Change-$0.30 (-9.68%)
VolumeN/A
Capitalization10.7M
Sol-Gel Technologies
Price$7.37
Change-$0.10 (-1.34%)
VolumeN/A
Capitalization20.42M
GTBP vs SLGL Comparison Chart in %
Loading...
GTBP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GTBP vs. SLGL commentary
Jul 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GTBP is a Hold and SLGL is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 04, 2025
Stock price -- (GTBP: $3.10 vs. SLGL: $7.47)
Brand notoriety: GTBP and SLGL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GTBP: 122% vs. SLGL: 2%
Market capitalization -- GTBP: $10.7M vs. SLGL: $20.42M
GTBP [@Biotechnology] is valued at $10.7M. SLGL’s [@Biotechnology] market capitalization is $20.42M. The market cap for tickers in the [@Biotechnology] industry ranges from $306.14B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GTBP’s FA Score shows that 1 FA rating(s) are green whileSLGL’s FA Score has 0 green FA rating(s).

  • GTBP’s FA Score: 1 green, 4 red.
  • SLGL’s FA Score: 0 green, 5 red.
According to our system of comparison, GTBP is a better buy in the long-term than SLGL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GTBP’s TA Score shows that 4 TA indicator(s) are bullish while SLGL’s TA Score has 5 bullish TA indicator(s).

  • GTBP’s TA Score: 4 bullish, 4 bearish.
  • SLGL’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, SLGL is a better buy in the short-term than GTBP.

Price Growth

GTBP (@Biotechnology) experienced а -7.86% price change this week, while SLGL (@Biotechnology) price change was -0.33% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.15%. For the same industry, the average monthly price growth was +33.42%, and the average quarterly price growth was +4.05%.

Reported Earning Dates

GTBP is expected to report earnings on May 15, 2025.

SLGL is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+7.15% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SLGL($20.4M) has a higher market cap than GTBP($10.7M). GTBP YTD gains are higher at: 1.508 vs. SLGL (-19.740). SLGL has higher annual earnings (EBITDA): -9.66M vs. GTBP (-12M). SLGL has more cash in the bank: 16.9M vs. GTBP (2.37M). GTBP has less debt than SLGL: GTBP (0) vs SLGL (1.18M). SLGL has higher revenues than GTBP: SLGL (12.1M) vs GTBP (0).
GTBPSLGLGTBP / SLGL
Capitalization10.7M20.4M52%
EBITDA-12M-9.66M124%
Gain YTD1.508-19.740-8%
P/E RatioN/AN/A-
Revenue012.1M-
Total Cash2.37M16.9M14%
Total Debt01.18M-
FUNDAMENTALS RATINGS
GTBP vs SLGL: Fundamental Ratings
GTBP
SLGL
OUTLOOK RATING
1..100
2553
VALUATION
overvalued / fair valued / undervalued
1..100
33
Fair valued
53
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10096
PRICE GROWTH RATING
1..100
3850
P/E GROWTH RATING
1..100
10098
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

GTBP's Valuation (33) in the null industry is in the same range as SLGL (53) in the Pharmaceuticals Major industry. This means that GTBP’s stock grew similarly to SLGL’s over the last 12 months.

GTBP's Profit vs Risk Rating (100) in the null industry is in the same range as SLGL (100) in the Pharmaceuticals Major industry. This means that GTBP’s stock grew similarly to SLGL’s over the last 12 months.

SLGL's SMR Rating (96) in the Pharmaceuticals Major industry is in the same range as GTBP (100) in the null industry. This means that SLGL’s stock grew similarly to GTBP’s over the last 12 months.

GTBP's Price Growth Rating (38) in the null industry is in the same range as SLGL (50) in the Pharmaceuticals Major industry. This means that GTBP’s stock grew similarly to SLGL’s over the last 12 months.

SLGL's P/E Growth Rating (98) in the Pharmaceuticals Major industry is in the same range as GTBP (100) in the null industry. This means that SLGL’s stock grew similarly to GTBP’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GTBPSLGL
RSI
ODDS (%)
Bearish Trend 2 days ago
86%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
88%
Momentum
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
79%
MACD
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 8 days ago
85%
Bullish Trend 11 days ago
76%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 7 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
GTBP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TDTH0.260.02
+9.71%
Trident Digital Tech Holdings Ltd
MAMA8.830.19
+2.20%
Mama's Creations
PLXS139.102.34
+1.71%
Plexus Corp
CAPL21.000.13
+0.62%
CrossAmerica Partners LP
EBAY75.78-0.32
-0.42%
eBay

SLGL and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLGL has been loosely correlated with TRAW. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if SLGL jumps, then TRAW could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLGL
1D Price
Change %
SLGL100%
+1.84%
TRAW - SLGL
46%
Loosely correlated
N/A
RAPT - SLGL
40%
Loosely correlated
+9.48%
GTBP - SLGL
33%
Loosely correlated
-8.94%
RPRX - SLGL
29%
Poorly correlated
+0.86%
EYPT - SLGL
28%
Poorly correlated
+1.15%
More